Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 551 participants.
Also called NCT03001817
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 551 participants
- Registry
-
NCT03001817
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Belarus, Bulgaria, Czechia, Georgia, Hungary, Poland, Russia, Ukraine
- Registry status
- Completed
Technical summary
Registry record NCT03001817. Randomized; triple masking; primary purpose treatment. Start 2016-11-28 (actual); primary completion 2019-06-24 (actual). Results posted on 2022-11-30.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function
- Condition
- Severe Hypertriglyceridemia
- Intervention (Drug)
- K-877
- Intervention (Drug)
- Fenofibrate
- Intervention (Drug)
- Placebo (for K-877)
- Intervention (Drug)
- Placebo (for Fenofibrate)
- Lead sponsor
- Kowa Research Institute, Inc.
Record details
- Record id
cardio:ct-nct03001817- Content hash
9956d4d154c72f03e911c201981e2b3aa915af1a4b6841e261fe7a7e13f0a0a9